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Abstract 
    Atrial fibrillation is the most common disorder of cardiac rhythm. In spite of simplicity of 
diagnosis, patients with atrial fibrillation are difficult to treat. In the recent years with the 
description of the phenomenon called remodelling, it has been possible to better define the 
principal mechanisms responsible for initiation, maintenance and, in some instances, termination 
of atrial fibrillation. Electrical, mechanical and anatomical remodelling indicate those alterations 
that, once established, may baffle any attempt to restore sinus rhythm. Atrial fibrosis is probably 
the most critical component of the remodelling process and appears to be mediated by several 
factors. Several kinds of arrhythmias, especially ventricular ones and conduction disturbances, 
can occur during percutaneous coronary interventions (PCI), resulting from excess catheter 
manipulation,   intracoronary   dye   injection,   new   ischemic   events,   or   reperfusion   injury. 
Supraventricular arrhythmias, including atrial flutter and atrial fibrillation (AF), may also occur 
during or after PCI, as a complication or a sequel of the revascularisation procedure. Also post 
operative AF is a common complication of coronary artery bypass surgery (CABG), occurring in 
5-40% of patients during the first postoperative week, depending on definitions and methods of 
detection. Experimental and clinical data will be discussed here.
Key Words: atrial fibrillation, percutaneous coronary intervention, coronary artery bypass 
surgery
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Atrial Fibrillation and Percutaneous Coronary Interventions                               
            Atrial fibrillation (AF) is the tachyarrhythmia that has the highest prevalence among all 
populations. It is clinically important because affected patients have a higher risk of mortality; a 
deterioration in haemodynamics due to increased heart rate, loss of atrioventricular synchrony, 
and progressive dysfunction of the left atrium and left ventricle; and stroke and other embolic 
events resulting from atrial thrombi1,2. In addition, AF may cause significant symptoms and 
impair both functional status and quality of life.                                                                 
            Percutaneous coronary interventions (PCI) have been the fastest growing major invasive 
procedure in the past decade. Accompanying the obvious benefit, there are certain risks, 
including cardiac arrhythmias. Several kinds of arrhythmias, especially ventricular arrhythmias 
and conduction disturbances, can occur during PCI. These arrhythmias may result from excess 
catheter manipulation, intracoronary dye injection, new ischemic events, or reperfusion injury, as 
also described in the PAMI Trials3.                                                                         
            Supraventricular arrhythmias, including atrial flutter and AF, may also occur during or 
after PCI, as a complication or a sequel of the revascularisation procedure. However, these are 
not as frequent as ventricular arrhythmias. In general, AF has prognostic significance in patients 
treated with PCI, as it can be induced by cardiac catheterisation, especially in response to 
catheter placement into or out of the right atrium4. Atrial dysfunction (due to atrial ischemia or 
atrial stretching in heart failure), sino-atrial and AV nodal ischemia, congestive heart failure, 
sympathetic stimulation, and iatrogenic factors are the possible causes of AF in patients 
undergoing primary PCI for acute myocardial infarction (MI).                                                       
Importance   of   Clinical   Features                                                                         
            The clinical characteristics of patients play an important role in the occurrence of AF 
during and after a PCI procedure. Kinjo et al.4 assessed the prognostic significance of AF and 
atrial flutter in patients with acute MI that had been treated with PCI. In their study, patients with 
AF were older and in higher Killip classes, had higher rates of previous MI and previous 
cerebrovascular accident, had systolic blood pressures of less than 100 mmHg and heart rates' 
value higher than 100 beats/min, were less likely to smoke, and had higher prevalence of 
multivessel disease and poorer reperfusion of infarct-related artery than those without AF. AF 
was a common complication in patients with MI who were treated with PCI and independently 
influenced 1-year mortality. Cardiogenic shock, congestive heart failure, cardiac rupture, 
ventricular tachycardia and/or ventricular fibrillation, and stroke occurred more often in patients 
with AF than in those with-out AF. No significant difference was observed in the rates of 
recurrent infarction or recurrent ischemia. The unadjusted in-hospital mortality rate was 
significantly higher in patients with AF than in those without AF. But, after adjustment for 
demographic  characteristics and clinical  factors,  AF  was  not  associated with  in-hospital 
mortality. Furthermore, when stratified by the timing of AF, both AF at admission and AF that 
developed during hospitalisation were not independent predictors for in-hospital mortality. 
Therefore, AF was not significantly associated with in-hospital mortality in patients with MI 
who underwent PCI. One-year mortality was higher in patients with AF than in those without 
AF. Most deaths were due to cardiovascular causes. Patients with AF had a greater incidence of 
death   due   to   pump   failure   than   those   without   AF.   After   adjustment   for   demographic 
characteristics and clinical factors, patients with AF remained at significantly greater risk for 
mortality at 1 year. Furthermore, when stratified by the timing of AF, AF during hospitalisation 
was independently associated with one year mortality, but AF at admission was not. The one 
year mortality of patients discharged alive was higher in those with AF than in those without AF. 
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After adjustment for demographic characteristics, clinical factors, and antiarrhythmic drug use at 
discharge, patients with AF remained at significantly greater risk for mortality at one year4.
Importance of Electrophysiological Predictors                                                                     
            Inhomogeneous prolongation of sinus impulses may predict the recurrence of AF. In two 
recent trials from Dilaveris et al. and Gorenek et al.5,6, P wave dispersion (P dispersion) was 
evaluated; it is commonly defined as the difference between the maximum and the minimum P 
wave duration, and maximum P wave duration (P maximum). In these trials, age, history of 
organic heart disease, P maximum, minimum P wave duration, and P dispersion were found to 
be significant univariate predictors of recurrent AF, whereas only P maximum and age remained 
significant independent predictors of frequent AF paroxysms in the multivariate analysis. 
Authors concluded that advanced age and prolonged P wave duration may be used as predictors 
of frequently relapsing AF. The presence of heterogeneous structural and electrophysiological 
properties in different portions of an atrium prone to fibrillate, may result in an inhomogeneous 
and discontinuous prolongation of sinus impulses7.                                                           
            Electrophysiological studies have demonstrated that individuals with a clinical history of 
AF have a significantly longer intra-atrial and inter-atrial conduction time of sinus impulses8-10. 
This has been confirmed by the finding of P-wave prolongation on 12-lead surface ECG and 
signal-averaged  ECG recordings11-13. The importance  of P-wave  dispersion in predicting 
recurrence of AF in patients with paroxysmal AF has also been elucidated5,14. Thus, P-wave 
signal-averaged ECG could be useful to identify patients at risk for recurrence of AF after 
internal   cardioversion15.                                                                    
               Ozmen et al.16  investigated the effects of angioplasty induced-ischemia on atrial 
conduction as estimated by P-wave maximum and P-wave dispersion. The study consisted of 67 
consecutive patients (41 men, mean age 58±11 years) with single vessel coronary artery disease 
who underwent elective single vessel coronary angioplasty (left anterior descending (LAD) 
coronary artery in 28 patients, the right coronary artery (RCA) in 22 patients and the left 
circumflex coronary artery (LCx) in 17 patients). All patients underwent 12-lead surface ECG 
before the first inflation (baseline) and then 60s after intra-coronary balloon inflation. The 
maximum P wave duration, the minimum P wave duration, and P wave dispersion (Pd = Pmax - 
Pmin) were calculated from 12-lead surface ECG. Both values of P maximum and P dispersion 
were significantly higher during balloon occlusion compared with the baseline condition in 
coronary dilatation procedures. However, the P-wave minimum was not found to differ between 
baseline and during balloon occlusion. These data demonstrate that prolongation of P-wave 
dispersion might be a simple and useful additional marker of myocardial ischemia during PCI.
            Budeus et al.17 examined the incidence of atrial late potentials in patients with a proximal 
stenosis of the right coronary artery and new onset of AF. They also investigated the anti-
ischemic effect of a successful percutaneous transluminal coronary angioplasty (PTCA) of the 
right coronary artery. After successful PTCA, only three of their 15 patients were affected after 
one day, as well as after one month. None of the patients with a history of AF suffered from an 
arrhythmic recurrence within the following 6 months after successful PTCA. In that study, 
stenosis of the right coronary artery was associated with positive atrial late potentials. The 
authors concluded that a successful PTCA of the right coronary artery eliminates pre-existent 
atrial late potentials and may reduce the risk of AF.                                                                   
Atrial Fibrillation in Acute MI. Thrombolytic vs. Primary PCI                                  
            Several studies in the thrombolytic era, showed that the prognostic significance of AF on 
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mortality was attenuated by improved treatment 18-20. Randomised studies performed in the past 
few years have shown that PCI is a more effective reperfusion strategy than intravenous 
thrombolysis21,22. Therefore, the incidence of AF may have decreased and the prognostic 
significance of AF may have been attenuated in patients with AMI who underwent PCI4. 
However, little is known concerning the incidence of AF and its effects on the prognosis of 
patients with AMI who are treated with PCI.                                                                 
            A study from Akdemir and coll.23 was conducted to compare the effects of reperfusion 
either by thrombolytic therapy or primary PTCA on P-wave duration and dispersion in patients 
with acute anterior wall MI. The Authors evaluated 72 consecutive patients, retrospectively, who 
had experienced an acute anterior wall MI for the first time. Patients were grouped according to 
the   reperfusion   therapy,   PTCA   versus   thrombolytic   therapy.   There   were   no   significant 
differences between the groups regarding age, gender, left ventricular ejection fraction (LVEF), 
left atrial diameter and volume, cardiovascular risk factors, and duration from symptom onset to 
treatment. P-wave dispersions and P-wave durations were significantly decreased after PTCA. In 
that study, primary PTCA reduced the incidence of AF by decreasing the P-wave maximum and 
P-wave   dispersion.                                                                          
               Gorenek and coll.24  examined the coronary angiographic findings of patients who 
developed AF during acute MI, and the effects of primary PCI and thrombolytic therapy for 
restoration of sinus rhythm. This study consisted of 52 patients with acute MI who underwent 
primary   PCI   or   had  thrombolytic   therapy  and  developed  AF   during  the  first  12  h  of 
hospitalisation. On admission, and 1 month later, coronary angiography was performed in all 
patients. In 26 of the 52 patients primary PCI was performed and in the other 26 patients 
thrombolytic therapy was applied (streptokinase or r-TPA) following angiography. Right 
coronary artery occlusions were the most frequent causes of AF (73%). In repeated coronary 
angiography, the coronary artery affected by the infarct was still totally occluded in five patients 
in the primary PCI group and eight patients in the thrombolytic therapy group (P < 0.01). At 
least TIMI-3 flow was observed in rest of the patients. Twenty-one patients in PCI group, and 16 
patients in thrombolytic therapy group were in sinus rhythm (SR) at the time of second coronary 
angiography, although there was no difference between the LVEFs of the groups, as determined 
by echocardiography at the time of the first coronary angiography. However, the LVEF of 
patients in the PCI group was higher at the time of second angiography. The authors concluded 
that the data showed that, because the patency of the infarct-related artery was better with 
primary PCI, this mode of treatment was superior to thrombolytic therapy in restoring sinus 
rhythm  in  acute  MI   patients.                                                                               
Recommendations  for   Management                                                                      
            Post-PCI AF has a propensity to revert spontaneously over a period of minutes to hours, 
so that, usually, it does not require immediate treatment unless it produces ischemia or 
hemodynamic instability. Specific recommendations based on trials in international literature for 
therapy in these patients, are nowadays preliminary and based on consensus, since no adequate 
trials will have tested alternate strategies.                                                                       
               Electrical   cardioversion   is   very   rarely   required.   But,   when   haemodynamic 
decompensation is prominent, electrical cardioversion is indicated, beginning with 50-100 joules 
with gradual increase if the initial shock is not successful. When necessary, a beta-blocker can be 
used for rate control, because of the combined effects of ischemia and sympathetic tone, which is 
usually increased in patients with AF. If an intravenous beta-blocker is preferred but it is 
uncertain whether such therapy will be tolerated by the patient, esmolol may be cautiously 
administrated since its very short half-life permits a therapeutic trial to be performed at reduced 
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risk. If esmolol is tolerated, then a moderate or long-acting beta-blocker can be given. These 
drugs can be also administered in combination. Intravenous doses of verapamil or diltiazem are 
attractive alternatives because of their ability to slow the ventricular rate promptly, but they 
should be used with caution in patients with pulmonary congestion. Due to the increased risk of 
embolism, intravenous anticoagulation with heparin should be instituted in the absence of any 
contraindications, moreover if AF is still present while the patient is in the coronary care unit or 
in his or her room. Amiodarone and dofetelide are also effective for acute control of the 
ventricular response, but generally are not recommended as the drug of choice for rate control. 
Digoxin is one of the drugs of choice and can be used especially in patients with congestive heart 
failure. Atrial flutter is generally well tolerated and also tends to revert spontaneously; when 
necessary, it can be treated with either burst atrial pacing or electrical or pharmacologic 
cardioversion.
Conclusions
            Atrial flutter may occur as a complication of PCI, but most of the time the patients' 
characteristics play important roles in the occurrence of this type of arrhythmia. For instance, 
ongoing acute MI can be the real reason for AF. Generally, AF tends to revert spontaneously, but 
treatment should be given promptly when necessary. If the patient is compromised by ventricular 
rate or by the loss of atrial contribution to cardiac output, synchronised DC cardioversion should 
be performed without delay. Intravenous beta-blockade can be effective for acute rate control. 
Calcium-channel blockers can be administered to promptly control ventricular rate. Digoxin, 
amiodarone and dofetilide are the drugs of choice for treating patients with acute MI with heart 
failure.
Atrial Fibrillation after Coronary Artery Bypass Grafting                                       
               Post operative atrial fibrillation (AF) is a common complication of coronary artery 
bypass surgery (CABG), occurring in 5-40% of patients during the first postoperative week, 
depending on definitions and methods of detection. A meta-analysis of controlled randomised 
trials   confirmed   that   in   trials   using   24-h   Holter   ECG   monitoring,   the   incidence   of 
supraventricular arrhythmias was higher with Holter recordings (41.3%) than in trials with-out 
(19.9%)25. Despite recent improvements in surgical techniques and postoperative patient care, 
the incidence of postoperative AF seems to increase, most likely related to the existence of an 
increasing number of elderly patients with co-morbidities. In the majority of cases postoperative 
AF is transient and not life-threatening, although it may cause marked subjective symptoms, 
congestive heart failure, hypotension, and ischaemia, requiring pharmacological treatment or 
electrical cardioversion, resulting in prolonged hospital stay and additional costs in medical 
care26.
            Stroke is a major adverse event, complicating the immediate outcome of CABG in about 
2% of cases. AF was reported to be a major determinant of stroke after CABG, preceding the 
occurrence of neurological complications in approximately 37% of the patients27. Apart from a 
higher risk of stroke (odds ratio, OR 2.02), postoperative AF was associated with greater in-
hospital mortality (OR 1.7) and worse survival (74% versus 87%) at long-term follow-up (4-5 
years)26. In a multivariate analysis it was an independent predictor of long-term mortality26. The 
complexity of distinguishing the intrinsic hazards due to postoperative AF from the risks related 
to its aetiological factors and treatment should, however, be recognised in this retrospective 
cohort   study.                                                                      
            The mechanisms responsible for postoperative AF are still unclear and are probably 
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multifactorial. Since risk stratification strategies for patients undergoing CABG could lead to 
more targeted preventive or therapeutic interventions, large number of trials have aimed at 
identifying risk factors for the development of postoperative AF. Risk factors associated with AF 
include advanced age (OR for 10-year increase, 1.75); history of AF (OR 2.11) or chronic 
obstructive lung disease (OR 1.43); valve surgery (OR 1.74); peripheral vascular disease (OR 
1.54); and postoperative withdrawal of (3-blockers (OR 1.91) or angiotensin-converting enzyme 
(ACE) inhibitors (OR 1.69)26,28.                                                                               
            Among preoperative risk factors, advancing age has a significant association with the 
incidence of AF, a relationship that is particularly important as the number of elderly patients 
considered for CABG steadily increases. Advanced age was associated with increased levels of 
circulating norepinephrine, which could be related to imbalance in the autonomic nervous sys-
tem, previously reported in some but not other studies as an independent risk factor for 
postoperative AF. Thoracic epidural anaesthesia, aimed at blocking excessive sympathetic 
activity, was, however, not effective in pre-venting postoperative AF29.                       
            There is still no consensus as to whether operative clinical and/or electrocardiographic 
characteristics further distinguish patients who would develop postoperative AF. Prolonged P-
wave duration consistent with intra-atrial conduction delay, the presence of preoperative 
supraventricular arrhythmias, and fluctuations in autonomic balance as measured by heart rate 
variability were identified in some but not other studies as independent risk factors for 
postoperative   AF30.                                                                                  
               Postoperative AF is probably the most important potentially reversible health care 
expenditure related to CABG. The recognition of the potential benefits of preventing AF after 
CABG is reflected by the large number of prophylactic strategies reported in the literature. In a 
meta-analysis including 42 randomised controlled trials, beta-blocking agents, sotalol, and 
amiodarone significantly reduced the incidence of postoperative AF compared with placebo, and 
with no marked difference between them31. The three drugs each prevented AF with the 
following odds ratios: beta-blockers 0.39, sotalol 0.35, and amiodarone 0.48)31. From the 
analysis of 10 pacing trials, atrial pacing was shown to be effective, with an odds ratio of 0.46 
for biatrial pacing31. Biatrial pacing significantly reduced length of hospital stay by 1.5 days, but 
there was no evidence that the stroke rate was lowered. In another meta-analysis32 evaluating the 
use of prophylactic anti-arrhythmic therapy (amiodarone, sotalol, procainamide, pacing) for the 
prevention of postoperative AF, the incidence of AF varied from 8% to 37% in the treatment 
groups and from 29% to 53% in the control groups, with a combined overall significant decrease 
of 0.52 (OR) in the treatment groups. When these studies were combined, there was 1,0±0,2 day 
overall decrease in length of hospital stay, but no significant effect on the incidence of stroke or 
mortality. Data on costs, available for five of the six studies that used amiodarone and one of the 
studies   that   used   pacing,   showed   a   combined   insignificant   decrease   in   cost32.
               In  another randomised study  from  Raddy  and coll.33, amiodarone plus  pacing 
significantly decreased the frequency of AF after open heart surgery, compared with amiodarone 
alone, pacing alone, and placebo. In the cost-effectiveness analysis, when compared with 
placebo, the probability of lower cost but higher effect (superiority) was 67% for amiodarone, 
15% for pacing, and 97% for amiodarone plus pacing33. In the multivariate analysis, preoperative 
beta-blockers and amiodarone were negatively associated with hospital costs (P < 0.05). Data 
suggest that both amiodarone alone and the combination of amiodarone plus pacing are cost-
effective   compared   with   placebo.                                                                        
               A  meta-analysis   of   8   prophylactic   pacing  trials34,   with   776  patients   enrolled, 
demonstrated a significant anti-arrhythmic effect of biatrial over-drive and fixed high-rate pacing 
and overdrive right atrial pacing, with a relative risk reduction of approximately 2.5-fold for 
new-onset AF at open heart surgery. Another larger meta-analysis of 58 studies35, conducted on 
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8565 patients, showed that prophylactic therapies (amiodarone, beta-blockers, sotalol, and 
pacing) favoured treatment for postoperative AF with an odds ratio of 0.43. A positive result for 
cost of hospitalisation in favour of treatment was achieved, but the statistic was not significant 
due to low power and large standard deviations. Beta-blockers had the greatest magnitude of 
effect across 28 trials (4074 patients), with an odds ratio of 0.35. The data for stroke favoured 
treatment by a non-significant effect size of 0.81. Similarly, a positive indication for length of 
stay was derived, but it too was not significant, with a weighted mean difference of -0.66.
            Hypomagnesaemia is frequently observed after cardiac surgery and is related to the 
extracorporeal circulation and the use of diuretics. In a meta-analysis of 17 trials with 2069 
patients36, magnesium supplementation reduced the risk of supraventricular arrhythmias (relative 
risk 0.77) but had no effect on the length of the hospital stay or mortality. Administration of 
prophylactic   magnesium   reduced   the   risk   of   postoperative   AF   by   29%,   although   the 
inhomogeneity   among   trials   may   limit   the   formulation   of   definitive   conclusions.
            The effect of cardiopulmonary bypass on the incidence of AF after CABG has been 
addressed in several trials. A meta-analysis37  of all observational studies comparing cardiac 
pulmonary bypass (2253 patients) and off-pump techniques (764 patients) in elderly patients 
demonstrated a significantly lower incidence of postoperative AF (odds ratio 0.70) after off-
pump surgery. The results were confirmed in another meta-analysis of 37 randomised trials 
(3369 patients)38, in which off-pump CABG significantly decreased AF (OR 0.58) and hospital 
stay (weighted mean difference, -1.0 days) but without affecting 30-day mortality or stroke rate 
(OR, 0.68). It should be emphasised, though, that the lower risk profile of patients undergoing 
off-pump CABG could contribute to a lower AF risk.                                                                   
            Radiofrequency ablation of pulmonary vein triggers has had a remarkable high success 
rate for non-postoperative AF. Our own data showed that onset of AF after CABG was triggered 
by premature beats in 72% of patients with postoperative AF, which implies that atrial triggers 
may be important in the postoperative setting. It is, however, as yet unclear whether a surgical 
epicardial   approach   would  be   effective   and   safe  if   implemented  during   routine  CABG 
procedures.
            The importance of the parasympathetic nervous system for the initiation of AF is still 
incompletely understood, although it is thought to play a role in the subsets of patients with 
paroxysmal non-postoperative AF. Vagal post-ganglionic neurons are located in well defined 
anatomic fat pads situated in two posterior epicardial regions around the heart and adjacent 
structures. Transvenous radiofrequency (RF) ablation at such sites has resulted in vagal 
denervation   and   improved   outcome   in   patients   with   non-postoperative   AF   subjected   to 
circumferential pulmonary vein ablation39. In animal studies the destruction of an anterior fat pad 
shown to contain vagal neurons resulted in decreased susceptibility to AF. The anterior fat pad, 
located in the aortopulmonary window, was therefore studied in humans with respect to its role 
in postoperative AF40. The authors' question was whether its removal, as routinely done during 
the process of placing the aortic cross-clamp, would decrease subsequent AF40. By stimulating 
the anterior fat pad in patients undergoing CABG, the sinus rate was slowed with no change in 
PR interval, consistent with innervation of the sinus node but not the atrioventricular node40. 
Since enhanced vagal tone is pro-fibrillatory in the atria by shortening refractoriness, the 
underlying theory was that removal of tissue responsible for vagal atrial influences would 
improve AF outcome. In this randomised study, paradoxically, 37% of patients in whom the 
interior fat pad was dissected developed postoperative AF compared with 7% in whom the fat 
pad was preserved40. Supportive of these findings is the reported lower incidence of AF after off-
pump CABG, during which the anterior fat pad is often preserved37. Animal experiments support 
vagal denervation as an effective anti-arrhythmic strategy, which is consistent with the finding of 
a lower incidence of AF following vagal denervation during catheter ablation procedures. The 
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importance of vagal influences and the role of the cardiac fat pads for developing postoperative 
AF   demand   further   clinical   research   to   determine   the   optimal   surgical   technique.
            The class I recommendations for prevention and management of postoperative AF are: 
(1) an oral beta-blocker for preventing AF, unless contraindicated (Class of Evidence: A) and (2) 
administration  of AV node  blocking agents to achieve rate control in patients who develop 
postoperative AF (Level of Evidence: B)41. Class Ila recommendations are: (1) prophylactic 
amiodarone for patients at increased risk of developing postoperative AF (Level of Evidence: 
A); (2) electrical or pharmacological cardioversion with ibutilide, when reasonable,  to restore 
sinus rhythm, as recommended for non-surgical patients (Level of Evidence: B); (3) attempt at 
maintenance of sinus rhythm by administration of anti-arrhythmic medications if there is 
recurrent or refractory postoperative AF, as recommended for patients with coronary artery 
disease who develop AF (Level of Evidence: B); and (4) anti-thrombotic medication in patients 
who develop post-operative AF, as recommended for non-surgical patients (Level of Evidence: 
B).
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